Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release
Z. Wang, S. V. Himanen, H. M. Haikala, C. C. Friedel, A. Vihervaara, M. Barboric
This study shows that inhibiting CDK12 in cancer cells activates P-TEFb, leading to increased dependence on P-TEFb for transcriptional elongation and hypersensitivity to P-TEFb inhibitors.
bioRxiv · Mar 21, 2023Cancer Biology